In response to COVID-19, GHX is committed to helping ensure that our customers receive access to the data and information needed to help maintain critical supplies to serve patients and protect staff. Click to learn more

Research & Insights

Topics

Ask Lumere: Can we choose a C. diff-associated diarrhea therapy based on cost?

NANS 2018 Annual Meeting: What’s New in Neuromodulation?

If Value Analysis Needs an Overhaul, What Should Clinical Decisions Look Like?

February 13, 2018

A Note from Our CEO: Procured Health Is Now Lumere

January 23, 2018

Overcoming Five Big Challenges in Analyzing Drug Utilization Data

January 18, 2018

Ask Lumere: Should sugammadex use be restricted?

December 11, 2017

Ask Lumere: How should physicians introduce new products?

December 11, 2017

“Value analysis as a stand-alone governance process is failing…”: An Interview with Lumere Leadership

December 6, 2017

Unpacking ORBITA: What the Controversial Stent Study Really Means

November 20, 2017

Ask Lumere: What evidence supports using heparin for PCI rather than bivalirudin?

November 7, 2017

1 2 3 4 5 6 7